Who Owns Neuphoria Therapeutics Stock?
NASDAQ: NEUPHealth CareBiotechnology: Pharmaceutical PreparationsUSD
Market open · Delayed 15 min · as of Oct 9, 10:11 AM ET
Ownership breakdown
- Held by institutions
- 43.34%
- Held by insiders
- 5.02%
- Institutional holders
- 24
- Institutions 43.3%
- Insiders 5.0%
- Public and other 51.6%
Who owns Neuphoria Therapeutics stock?
Institutional investors own about 43.3% of Neuphoria Therapeutics's shares, spread across 24 institutions that file 13F reports. That level of institutional ownership is moderate. Insiders, including executives, directors and large founding shareholders, hold 5.02% of NEUP.
The largest institutional holders are Lynx1 Capital Management Lp (16.18%), AdvisorShares Investments, LLC (4.67%) and Vanguard Capital Management LLC (3.21%). Together, the top 10 institutions control 33.9% of shares outstanding. In their latest filings, 6 of the top 10 institutions increased their NEUP positions and 1 reduced them.
Summary generated from market data by MetaCap's automated system. Methodology
Top institutional holders of NEUP
| Institution | Shares | % Held | Change |
|---|---|---|---|
| Lynx1 Capital Management Lp | 875.33K | 16.18% | 0.0% |
| AdvisorShares Investments, LLC | 252.91K | 4.67% | +62.8% |
| Vanguard Capital Management LLC | 173.49K | 3.21% | +76.1% |
| Shay Capital LLC | 155.82K | 2.88% | +3.2% |
| Balyasny Asset Management LP | 142.23K | 2.63% | +0.0% |
| Citadel Advisors Llc | 72.56K | 1.34% | +275.4% |
| Geode Capital Management, LLC | 49.52K | 0.92% | -4.8% |
| Ikarian Capital, LLC | 47.44K | 0.88% | 0.0% |
| Vanguard Fiduciary Trust Co | 33.81K | 0.62% | +0.7% |
| Adar1 Capital Management, LLC | 30.00K | 0.55% | 0.0% |
% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.
Top mutual fund and ETF holders of NEUP
| Fund | Shares | % Held |
|---|---|---|
| AdvisorShares Trust-AdvisorShares Psychedelics ETF | 312.89K | 5.78% |
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 110.17K | 2.04% |
| VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund | 63.32K | 1.17% |
| Fidelity Concord Street Trust-Fidelity Extended Market Index Fund | 28.05K | 0.52% |
| Fidelity Concord Street Trust-Fidelity Series Total Market Index Fund | 8.04K | 0.15% |
| Fidelity Concord Street Trust-Fidelity Nasdaq Composite Index Fund | 2.43K | 0.04% |
| Fidelity Concord Street Trust-Fidelity Total Market Index Fund | 2.00K | 0.04% |
Frequently asked questions
Who is the largest shareholder of Neuphoria Therapeutics?
Lynx1 Capital Management Lp is the largest institutional shareholder of NEUP, owning 16.18% of shares outstanding (875.33K shares) as of its latest 13F filing.
What percentage of Neuphoria Therapeutics is owned by institutions?
Institutions own about 43.3% of NEUP shares and 45.6% of the public float.
How much of Neuphoria Therapeutics do insiders own?
Insiders, such as officers and directors, own about 5.02% of NEUP shares outstanding.
Where does institutional ownership data come from?
Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.